Advanced Biomedical Technologies (ABMT) Stock Price, News & Analysis

Company Overview

Advanced Biomedical Technologies, Inc. (OTCMKTS:ABMT) is a development-stage biotechnology company focused on the research and development of immunotherapeutic and diagnostic solutions for chronic liver diseases. Headquartered in Boca Raton, Florida, the company leverages proprietary antigen constructs and adjuvant platforms to create vaccine candidates aimed at stimulating host immune responses against persistent viral infections of the liver.

ABMT’s product pipeline includes immunotherapeutic vaccine candidates targeting hepatitis B virus (HBV) and hepatitis D virus (HDV), as well as companion diagnostics designed to detect active viral replication and assess fibrotic progression. These diagnostic assays utilize molecular markers associated with liver inflammation and fibrosis, enabling clinicians to monitor disease status and evaluate therapeutic efficacy.

The company’s technology is built on a portfolio of patented antigen and adjuvant formulations that are intended to enhance the body’s ability to clear or control chronic viral infections. ABMT collaborates with academic research centers, contract research organizations and regulatory authorities to advance its candidates through preclinical validation and early-stage clinical studies.

As a small-cap, development-stage firm trading on the OTC Markets, Advanced Biomedical Technologies pursues strategic partnerships, grant funding and licensing agreements to support the progression of its pipeline toward commercial milestones. The company’s long-term objective is to address significant unmet needs in the global management of viral and fibrotic liver diseases through innovative immunotherapeutic and diagnostic products.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ABMT Stock Analysis - Frequently Asked Questions

How do I buy shares of Advanced Biomedical Technologies?

Shares of ABMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Advanced Biomedical Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Biomedical Technologies investors own include Ashford Hospitality Trust (AHT), Peabody Energy (BTU), PlayAGS (AGS), Assertio (ASRT), Astronics (ATRO), CONSOL Coal Resources (CCR) and Acorda Therapeutics (ACOR).

Company Calendar

• Today: 9/16/2025
• Fiscal Year End: 10/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:ABMT
• CIK: 1385799
• Web: abtlafleur.com
• Phone: (718) 766-7898
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $270 thousand
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A